Functional Outcome Following Stroke Thrombectomy in Clinical Practice.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 25 7 2019
medline: 13 3 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Background and Purpose- Endovascular treatment for large vessel occlusion in ischemic stroke has proven to be effective in large clinical trials. We aimed to provide real-world estimates of endovascular treatment reperfusion rates and functional outcome on a countrywide scale. Methods- Two thousand seven hundred ninety-four patients with large vessel occlusion were included into an investigator-initiated, industry-independent, prospective registry in 25 sites in Germany between June 2015 and April 2018. The primary outcome was the score on the modified Rankin Scale ranging from zero (no symptoms) to 6 (death) at 3 months. Secondary analyses included the prediction of a good outcome (modified Rankin Scale, 0-2). Dichotomized analyses of predictors were performed using logistic regression adjusted for potential confounders. Results- Median age was 75 years (interquartile range, 64-82); median National Institutes of Health Stroke Scale score was 15 (interquartile range, 10-19). Vessel occlusion was in the anterior circulation in 2265 patients (88%) and in the posterior circulation in 303 patients (12%). Intravenous alteplase before endovascular treatment was given in 1457 patients (56%). Successful reperfusion was achieved in 2143 subjects (83%). At 3 months, 854 patients (37%) showed a good outcome; mortality was 29%. There was no difference between anterior and posterior circulation occlusions (P=0.27). Significant predictors for a good outcome were younger age (odds ratio [OR], 1.06; 95% CI, 1.05-1.07), no interhospital transfer (OR, 1.39; 95% CI, 1.03-1.88), lower stroke severity (OR, 1.10; 95% CI, 1.08-1.13), smaller infarct size (OR, 1.26; 95% CI, 1.15-1.39), alteplase use (OR, 1.49; 95% CI, 1.08-2.06), and reperfusion success (OR, 1.69; 95% CI, 1.45-1.96). Conclusions- High rates of favorable outcome can be achieved on a countrywide scale by endovascular treatment. Mortality appears to be greater in the daily routine than otherwise reported by authors of large randomized trials. There were no outcome differences between the anterior and posterior circulation. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT03356392.

Identifiants

pubmed: 31337298
doi: 10.1161/STROKEAHA.119.026005
doi:

Substances chimiques

Tissue Plasminogen Activator EC 3.4.21.68

Banques de données

ClinicalTrials.gov
['NCT03356392']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2500-2506

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Frank A Wollenweber (FA)

From the Institute for Stroke and Dementia Research (F.A.W., S.T., M.D.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.
Department of Neurology (F.A.W., L. Kellert), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

Steffen Tiedt (S)

From the Institute for Stroke and Dementia Research (F.A.W., S.T., M.D.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

Anna Alegiani (A)

Department of Neurology (A.A., C.G., G.T.), University Medical Center Hamburg-Eppendorf, Germany.

Burkhard Alber (B)

Department of Neurology, Bezirkskrankenhaus Günzburg, Germany (B.A., G.F.H.).

Christopher Bangard (C)

Department of Radiology, Institut für Diagnostische und Interventionelle Radiologie (C.B.), Klinikum Hanau, Germany.

Jörg Berrouschot (J)

Department of Neurology (J.B.), Klinikum Altenburger Land, Germany.

Felix J Bode (FJ)

Department of Neurology (F.J.B., G.C.P.), University Hospital Bonn, Germany.

Tobias Boeckh-Behrens (T)

Department of Neuroradiology, Klinikum rechts der Isar Technical University Munich, Germany (T.B.-B., M.L.).

Georg Bohner (G)

Department of Neuroradiology, Institute of Neuroradiology (G.B., E.S.), Charite Universitary Medicine Berlin, Germany.

Albrecht Bormann (A)

Department of Neuroradiology (A.B.), Klinikum Altenburger Land, Germany.

Michael Braun (M)

Department of Radiology, Sektion Neuroradiologie Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Ulm, BKH-Günzburg, Germany (M.B.).

Franziska Dorn (F)

Department of Neuroradiology (F.D., M.H.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

Bernd Eckert (B)

Department of Neuroradiology, Institut für Radiologie und Neuroradiologie, Asklepios Klinik Altona, Hamburg, Germany (B.E.).

Fabian Flottmann (F)

Department of Neuroradiology (F.F., J.F.), University Medical Center Hamburg-Eppendorf, Germany.

Gerhard F Hamann (GF)

Department of Neurology, Bezirkskrankenhaus Günzburg, Germany (B.A., G.F.H.).

Karl-Heinz Henn (KH)

Department of Neurology, Sana Klinikum Offenbach, Germany (K.-H.H., A.S.).

Moriz Herzberg (M)

Department of Neuroradiology (F.D., M.H.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

Andreas Kastrup (A)

Department of Neurology, Klinikum Bremen Mitte, Germany (A.K.).

Lars Kellert (L)

Department of Neurology (F.A.W., L. Kellert), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

Christoffer Kraemer (C)

Department of Neurology, Stadtisches Klinikum Lüneburg, Germany (C.K.).

Lars Krause (L)

Department of Neurology (L. Krause, M.P.), Klinikum Osnabrück, Germany.

Manuel Lehm (M)

Department of Neuroradiology, Klinikum rechts der Isar Technical University Munich, Germany (T.B.-B., M.L.).

Jan Liman (J)

Department of Neurology (J.L.), University Medical Center Goettingen, Germany.

Stephan Lowens (S)

Department of Radiology (S.L.), Klinikum Osnabrück, Germany.

Anastasios Mpotsaris (A)

Department of Neuroradiology (A.M.), RWTH Aachen University, Germany.

Panagiotis Papanagiotou (P)

Department of Neuroradiology, Clinic for Diagnostic and Interventional Neuroradiology, Hospitals, Bremen-Mitte, Germany (P.P.).

Martina Petersen (M)

Department of Neurology (L. Krause, M.P.), Klinikum Osnabrück, Germany.

Gabor C Petzold (GC)

Department of Neurology (F.J.B., G.C.P.), University Hospital Bonn, Germany.
German Center for Neurodegenerative Diseases, Bonn, Germany (G.C.P., M.D.).

Waltraud Pfeilschifter (W)

Department of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany (W.P., J.-H.S.).

Marios-Nikos Psychogios (MN)

Department of Neuroradiology (M.-N.P.), University Medical Center Goettingen, Germany.
Department of Neuroradiology, Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Switzerland (M.-N.P.).

Arno Reich (A)

Department of Neurology (A.R.), RWTH Aachen University, Germany.

Regina von Rennenberg (R)

Department of Neurology (R.v.R., S.Z., C.H.N.), Charite Universitary Medicine Berlin, Germany.

Joachim Röther (J)

Department of Neurology, Neurologische Abteilung, Asklepios Klinik Altona, Hamburg, Germany (J.R.).

Jan-Hendrik Schäfer (JH)

Department of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany (W.P., J.-H.S.).

Eberhard Siebert (E)

Department of Neuroradiology, Institute of Neuroradiology (G.B., E.S.), Charite Universitary Medicine Berlin, Germany.

Andreas Siedow (A)

Department of Neurology, Sana Klinikum Offenbach, Germany (K.-H.H., A.S.).

Laszlo Solymosi (L)

Department of Neuroradiology (L.S.), University Hospital Bonn, Germany.

Sven Thonke (S)

Department of Neurology (S.T.), Klinikum Hanau, Germany.

Marlies Wagner (M)

Department of Neuroradiology, Institute of Diagnostic and Interventional Neuroradiology, Frankfurt am Main, Germany (M.W.).

Silke Wunderlich (S)

Department of Neurology, Clinic and Policlinic for Neurology, Hospital of the Technical University Munich, Germany (S.W.).

Sarah Zweynert (S)

Department of Neurology (R.v.R., S.Z., C.H.N.), Charite Universitary Medicine Berlin, Germany.

Christian H Nolte (CH)

Department of Neurology (R.v.R., S.Z., C.H.N.), Charite Universitary Medicine Berlin, Germany.

Christian Gerloff (C)

Department of Neurology (A.A., C.G., G.T.), University Medical Center Hamburg-Eppendorf, Germany.

Götz Thomalla (G)

Department of Neurology (A.A., C.G., G.T.), University Medical Center Hamburg-Eppendorf, Germany.

Martin Dichgans (M)

From the Institute for Stroke and Dementia Research (F.A.W., S.T., M.D.), Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.
German Center for Neurodegenerative Diseases, Bonn, Germany (G.C.P., M.D.).

Jens Fiehler (J)

Department of Neuroradiology (F.F., J.F.), University Medical Center Hamburg-Eppendorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH